Supplementary Figure S2 from The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models

Read full text Summarise with VIRAT
Authors: Jianhui Ma, Sayee G. Hegde, Masha Sergeeva, Binita Chakraborty, Suzanne E. Wardell, Donald Patrick McDonnell, Peter Q. Huang, Kevin D. Bunker, Fernando Doñate, Mark R. Lackner, Ahmed A. Samatar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Supplementary Figure S2 shows ZN-c5 demonstrates minor agonist effect on uterine tissue A. Uterine wet weight change in juvenile rats treated with different doses of ZN-c5. B. H&E staining on uterine tissues after ZN-c5 treatment. Images were digitally scanned at 20X magnification

Fields of Study & Subjects

Estrogen and related hormone effects Protein Degradation and Inhibitors Advanced Breast Cancer Therapies

Publication details

Publication date
2 April 2026
Language
EN